Dr. Benza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Gustave Levy Place Box 103
Hess building
New York, NY 10029Phone+1 412-304-8866Fax+1 212-824-8918- Is this information wrong?
Summary
- Professor and System Director for Pulmonary Vascular Diseases at the Icahn School of Medicine at Mount Sinai. He is a Fellow of the AHA and ACC. He holds positions in the PVRI, ISHLT and served on President Barack Obama’s Committee on Organ Transplantation. He was knighted in 2015 for his philanthropic work. Dr. Benza is a Clinical Trialist and funded investigator for the NHLBI and the AHA.
Education & Training
- University of Alabama Medical CenterChief Residency, Cardiovascular Disease, 1996 - 1997
- University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
- University of Michigan Health SystemResidency, Internal Medicine, 1990 - 1992
- University of Michigan Health SystemInternship, Internal Medicine, 1989 - 1990
- University of Florida College of MedicineClass of 1989
Certifications & Licensure
- NY State Medical License 1992 - 2025
- OH State Medical License 2020 - 2024
- PA State Medical License 2008 - 2021
- AL State Medical License Active through 2008
- MI State Medical License 1991 - 1995
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- Association of University Cardiologists 2021
- Bob and Corrine Endowed Chair of Heart Failure The Ohio State University, 2020
- Best Doctors Pittsburgh 2013-2020
- Join now to see all
Clinical Trials
- REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management Start of enrollment: 2006 Mar 01
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
- Pharmacogenomics in Pulmonary Arterial Hypertension Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.Sandeep Sahay, Nelson Villasmil Hernandez, Fredrick Wang, Matthew Wooten, Duc T Nguyen, Charles Fauvel, Raymond Benza, Edward A Graviss> ;Chest. 2024 Mar 4
- Risk scores as a surrogate in pulmonary arterial hypertension: a different lens.R James White, Daniel J Lachant, Raymond L Benza> ;The Lancet. Respiratory Medicine. 2024 Mar 1
- The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.Ekkehard Grünig, Peter Sandner, Johannes-Peter Stasch, Gérald Simonneau, Raymond L Benza> ;European Respiratory Review. 2024 Jan 31
- Join now to see all
Journal Articles
- Clinical Research A Bayesian Model to Predict Survival After Left Ventricular Assist Device ImplantationStephen H Bailey, Srinivas Murali, Joseph G Rogers, Raymond Benza, Jeffrey J Teuteberg, Colleen K McIlvennan, Robert L Kormos, JoAnn Lindenfeld, ScienceDirect
Press Mentions
- OSU Wexner Launches 'Hospital-at-Home' Program for Patients with Heart FailureJanuary 28th, 2022
- WellSky® to Deliver in-Home Protocols for Patients with Heart FailureJanuary 27th, 2022
- United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021October 21st, 2021
- Join now to see all
Grant Support
- VITA: Vascular Interventions/Innovations and Therapeutic AdvancesNational Heart, Lung and Blood Institute2014–Present
- Salivary Gland-Based Gene Therapy for Pulmonary Arterial HypertensionNational Heart, Lung and Blood Institute2013–Present
- Pulmonary Hypertension Breakthrough InitiativeAmerican Heart Association2008–Present
- Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2008
- Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2005–2007
- Genetic Determination Of Allograft VasculopathyNational Heart, Lung, And Blood Institute1998–2002
Committees
- Member, Advisory Council Organ Transplantation, HRSA 2010 - Present
- member, United Network of Organ Sharing Thoracic Council 2009 - Present
Professional Memberships
- Member
- Fellow
- Fellow
- Member
- Fellow
- Member
- International Society of Heart and Lung TransplantationBoard of Directors
- Member
Industry Relationships
- Chief Medical officer, PHopeCompany focused on interventional therapies for pulmonary arterial hypertension2023 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: